LEADER 00928nam a22002411i 4500 001 991003794729707536 005 20040610073233.0 008 040802s1951 fr |||||||||||||||||fre 035 $ab1312903x-39ule_inst 035 $aARCHE-108164$9ExL 040 $aBiblioteca Interfacoltà$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a842.91 100 1 $aRoussin, André$0466308 245 10$aBobosse ; suivi de Les oeufs de l'autruche /$cAndré Roussin 260 $aMonaco :$bÉditions du Rocher,$c1951 300 $a252 p. ;$c17cm 440 4$aLes livres de Poche 907 $a.b1312903x$b02-04-14$c05-08-04 912 $a991003794729707536 945 $aLE002 Fondo Giudici L 128$g1$i2002000308894$lle002$nC. 1$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i13765280$z05-08-04 996 $aBobosse; suivi de Les oeufs de l'autruche$9202039 997 $aUNISALENTO 998 $ale002$b05-08-04$cm$da $e-$ffre$gfr $h0$i1 LEADER 05354nam 2200697 a 450 001 9911020447803321 005 20200520144314.0 010 $a9786610367863 010 $a9781280367861 010 $a1280367865 010 $a9780470307663 010 $a0470307668 010 $a9780471533405 010 $a0471533408 010 $a9780471533771 010 $a0471533777 035 $a(CKB)111087027116224 035 $a(EBL)468793 035 $a(OCoLC)814412893 035 $a(SSID)ssj0000231781 035 $a(PQKBManifestationID)11225886 035 $a(PQKBTitleCode)TC0000231781 035 $a(PQKBWorkID)10208995 035 $a(PQKB)10579166 035 $a(MiAaPQ)EBC468793 035 $a(Perlego)2773963 035 $a(EXLCZ)99111087027116224 100 $a20040624d2004 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aQuinoxalines$hSupplement II /$fD.J. Brown 210 $aHoboken, N.J. $cWiley$dc2004 215 $a1 online resource (528 p.) 225 1 $aThe chemistry of heterocyclic compounds ;$vv. 61 300 $a"Interscience publication." 311 08$a9780471264958 311 08$a0471264954 320 $aIncludes bibliographical references (p. 437-470) and index. 327 $aQUINOXALINES Supplement II; Preface; Contents; CHAPTER 1 PRIMARY SYNTHESES; 1.1 From a Single Benzene Substrate; 1.1.1 By Formation of the N1,C8a Bond; 1.1.2 By Formation of the N1,C2 Bond; 1.1.2.1 Cyclization of o-(Ethylamino)aniline Derivatives; 1.1.2.2 Direct Cyclization of o-(Ethylamino)nitrobenzene Derivatives; 1.1.2.3 Reductive Cyclization of o-(Ethylamino)nitrobenzene Derivatives; 1.1.3 By Formation of the C2,C3 Bond; 1.2 From a Benzene Substrate with an Ancillary Synthon; 1.2.1 When the Synthon Supplies N1 of the Quinoxaline; 1.2.2 When the Synthon Supplies C2 of the Quinoxaline 327 $a1.2.3 When the Synthon Supplies C2 + C3 of the Quinoxaline1.2.3.1 Using a Dialdehyde (Glyoxal) or Related Synthon; 1.2.3.2 Using an Aldehydo Ketone or Related Synthon; 1.2.3.3 Using an Aldehydo Acid or Related Synthon; 1.2.3.4 Using an Aldehydo Ester or Related Synthon; 1.2.3.5 Using an Aldehydo Amide, Nitrile, Acyl Halide, or Related Synthon; 1.2.3.6 Using a Diketone or Related Synthon; 1.2.3.7 Using a Keto Acid or Related Synthon; 1.2.3.8 Using a Keto Ester or Related Synthon; 1.2.3.9 Using a Keto Amide, Nitrile, Acyl Halide, or Related Synthon 327 $a1.2.3.10 Using a Diacid (Oxalic Acid) as Synthon1.2.3.11 Using a Diester (a Dialkyl Oxalate) or Related Synthon; 1.2.3.12 Using an Estero Amide, Nitrile, Acyl Halide, or Related Synthon; 1.2.3.13 Using a Diamide (Oxamide), Amido Nitrile, or Related Synthon; 1.2.3.14 Using a Diacyl Dihalide (Oxalyl Halide) or Related Synthon; 1.2.4 When the Synthon Supplies N1 + C2 + C3 of the Quinoxaline; 1.2.5 When the Synthon Supplies N1 + C2 + C3 + N4 of the Quinoxaline; 1.3 From a Benzene Substrate with Two or More Synthons; 1.4 From a Pyrazine Substrate with or without Synthon(s) 327 $a1.5 From Other Heteromonocyclic Substrates/Synthons1.5.1 Azirines as Substrates/Synthons; 1.5.2 1,2,3-Dithiazol-1-iums as Substrates/Synthons; 1.5.3 Furans as Substrates/Synthons; 1.5.4 Isothiazoles as Substrates/Synthons; 1.5.5 Isoxazoles as Substrates/Synthons; 1.5.6 Oxazoles as Substrates/Synthons; 1.5.7 Oxirenes as Substrates/Synthons; 1.5.8 Pyrans as Substrates/Synthons; 1.5.9 Pyridazines as Substrates/Synthons; 1.5.10 Pyridines as Substrates/Synthons; 1.5.11 Pyrimidines as Substrates/Synthons; 1.5.12 Pyrroles as Substrates/Synthons; 1.5.13 Thiophenes as Substrates/Synthons 327 $a1.5.14 1,2,4-Triazines as Substrates/Synthons1.5.15 1,2,3-Triazoles as Substrates/Synthons; 1.6 From Heterobicyclic Substrates/Synthons; 1.6.1 7-Azabicyclo[4.1.0]heptanes as Substrates/Synthons; 1.6.2 Benzimidazoles as Substrates/Synthons; 1.6.3 1,4-Benzodiazepines as Substrates/Synthons; 1.6.4 1,5-Benzodiazepines as Substrates/Synthons; 1.6.5 1-Benzopyrans (Chromenes) as Substrates/Synthons; 1.6.6 2,1,3-Benzoselena(or thia)diazoles as Substrates/Synthons; 1.6.7 2,1,3-Benzoxadiazoles as Substrates/Synthons; 1.6.8 Cycloheptapyrazines as Substrates/Synthons; 1.6.9 Indoles as Substrates/Synthons 327 $a1.6.10 Pyrrolo[3,4-b]pyrazines as Substrates/Synthons 330 $aThis volume in the Chemistry of Heterocyclic Compounds series presents a comprehensive review of the quinoxaline literature from 1975 to the present (2002), updating Volumes 5 and 35. It provides an alphabetical table of known simple quinoxalines, including new compounds discussed in this volume and their physical data, as well as the pyrazines from the original volumes. Biological activities, spectral or other physical studies, and other such materials appear at appropriate points in the text. The in-depth coverage includes synthesis, reactions, spectroscopic, and physical properties for each 410 0$aChemistry of heterocyclic compounds ;$vv. 61. 606 $aQuinoxalines 615 0$aQuinoxalines. 676 $a547.593 676 $a547/.59/05 700 $aBrown$b D. J$0383088 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911020447803321 996 $aQuinoxalines$94416514 997 $aUNINA